CSIMarket
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


United Cannabis's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CNAB Gross Profit Margin (Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Revenue Change 112.77 % 1557.07 % - 1977.05 % 1034.34 %
Y / Y Gross Profit Change 192.23 % 509.89 % 2302.29 % 639.56 % 539.98 %
Gross Profit Margin 34.55 % 20.36 % 7.47 % 26.51 % 25.16 %
Gross Profit Margin Total Ranking # 2785 # 3330 # 3815 # 3086 # 3245
Seq. Revenue Change -10.22 % 47.86 % 39.95 % 14.53 % 599.21 %
Seq. Gross Profit Change 52.32 % 302.85 % -60.54 % 20.69 % 217.89 %


Commenting Second Quarter 2019 Gross Profit Margin
Despite sequential Revenue deterioration in II. Quarter of -10.22 % United Cannabis Corp managed to reduce Cost of Sales and increase Gross Profit by 52.32 % to $1 millions. Gross Profit Margin grew to 34.55 %, below company average Gross Profit Margin.

Observing second quarter 2019 results within Biotechnology & Drugs industry 98 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2785, from total ranking in previous quarter at 3330.
Learn about Gross Margin
CNAB's Gross Profit Margin second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 99
Healthcare Sector # 449
Overall # 2785

Gross Profit Margin Statistics
High Average Low
97.66 % 52.96 % 7.47 %
(Sep 30 2014)   (Dec 31 2018)



Financial Statements
United Cannabis's (Jun 30 2019) Gross Profit $ 1 CNAB's Income Statement
United Cannabis's (Jun 30 2018) Gross Profit $ 0 Quarterly CNAB's Growth
CNAB's Profits by Division See CNAB's Profits by Segment

Other Gross Profit Margin Profitability Ratios
CNAB's Cumulative Gross Profit Margin
Biotechnology & Drugs Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CNAB's Gross Profit Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CNAB's Competitors
Gross Profit Margin Profit Margin for United Cannabis's Suppliers
Gross Profit Margin Profit Margin for CNAB's Customers

You may also want to know
CNAB's Annual Growth Rates CNAB's Profitability Ratios CNAB's Asset Turnover Ratio CNAB's Dividend Growth
CNAB's Roe CNAB's Valuation Ratios CNAB's Financial Strength Ratios CNAB's Gross Profit Growth
CNAB's Roa CNAB's Inventory Turnover Ratio CNAB's Growth Rates CNAB's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2019, within Biotechnology & Drugs Industry Gross Profit MarginJun 30 2019 MRQ Gross ProfitJun 30 2019 MRQ Revenue
Ctd Holdings Inc  94.03 %$ 0.257 $ 0.273 
Gtx Corp  92.94 %$ 0.778 $ 0.837 
Organovo Holdings, Inc.  92.37 %$ 0.617 $ 0.668 
Spark Therapeutics, Inc.  90.39 %$ 12.206 $ 13.503 
La Jolla Pharmaceutical Co  90.34 %$ 5.152 $ 5.703 
Therapeutic Solutions International, Inc.  88.40 %$ 0.008 $ 0.009 
Biogen Inc.  86.83 %$ 3,140.400 $ 3,616.700 
Biotime Inc  86.26 %$ 0.672 $ 0.779 
Allergan Plc  84.05 %$ 3,437.800 $ 4,090.100 
Myriad Genetics Inc  83.86 %$ 114.800 $ 136.900 
Gilead Sciences, Inc.  82.41 %$ 4,685.000 $ 5,685.000 
Acorda Therapeutics Inc  81.23 %$ 40.656 $ 50.053 
Abbvie Inc.  77.96 %$ 6,436.000 $ 8,255.000 
Conversion Labs, Inc.  75.72 %$ 2.043 $ 2.698 
Regenxbio Inc.  75.55 %$ 5.954 $ 7.881 
Neuronetics, Inc.  74.83 %$ 12.401 $ 16.572 
Oxford Immunotec Global Plc  72.43 %$ 14.188 $ 19.588 
Cv Sciences, Inc.  70.91 %$ 11.951 $ 16.854 
Nanostring Technologies Inc  68.35 %$ 20.740 $ 30.345 
Innovus Pharmaceuticals, Inc.  65.60 %$ 4.492 $ 6.848 
Vericel Corp  65.50 %$ 17.129 $ 26.151 
Nymox Pharmaceutical Corporation  65.00 %$ 0.013 $ 0.020 
U.s. Stem Cell, Inc.  61.02 %$ 0.792 $ 1.298 
Aerie Pharmaceuticals, Inc.  58.80 %$ 9.311 $ 15.835 
Emergent Biosolutions Inc.  58.55 %$ 142.400 $ 243.200 
Meridian Bioscience Inc  58.34 %$ 28.259 $ 48.440 
Fulgent Genetics, Inc.  57.03 %$ 4.804 $ 8.424 
Repligen Corp  56.56 %$ 39.984 $ 70.692 
Chromadex Corp.  56.34 %$ 6.254 $ 11.101 
Quidel Corp  54.67 %$ 59.179 $ 108.252 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OXIS's Profile

Stock Price

OXIS's Financials

Business Description

Fundamentals

Charts & Quotes

OXIS's News

Suppliers

OXIS's Competitors

Customers & Markets

Economic Indicators

OXIS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071